OPKO Health Inc. [NASDAQ: OPK] stock went on a downward path that fall over -5.36% on Friday, amounting to a one-week price increase of more than 15.22%. The company report on July 20, 2020 that OPKO Health’s BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC).
CDC chooses BioReference as one of the antibody testing and service providers for national serological survey.
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the Centers for Disease Control and Prevention (CDC).
Over the last 12 months, OPK stock rose by 154.81%. The one-year OPKO Health Inc. stock forecast points to a potential downside of -7.07. The average equity rating for OPK stock is currently 1.80, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $3.75 billion, with 640.58 million shares outstanding and 403.19 million shares in the current float. Compared to the average trading volume of 16.52M shares, OPK stock reached a trading volume of 19772636 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on OPKO Health Inc. [OPK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OPK shares is $4.95 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OPK stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Jaffray have made an estimate for OPKO Health Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 25, 2019. The new note on the price target was released on March 02, 2018, representing the official price target for OPKO Health Inc. stock. On June 21, 2016, analysts increased their price target for OPK shares from 16 to 18.
The Average True Range (ATR) for OPKO Health Inc. is set at 0.43, with the Price to Sales ratio for OPK stock in the period of the last 12 months amounting to 4.21. The Price to Book ratio for the last quarter was 2.19, with the Price to Cash per share for the same quarter was set at 0.05.
OPK Stock Performance Analysis:
OPKO Health Inc. [OPK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.22. With this latest performance, OPK shares gained by 107.03% in over the last four-week period, additionally plugging by 235.44% over the last 6 months – not to mention a rise of 154.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OPK stock in for the last two-week period is set at 71.27, with the RSI for the last a single of trading hit 68.97, and the three-weeks RSI is set at 71.06 for OPKO Health Inc. [OPK]. The present Moving Average for the last 50 days of trading for this stock 3.19, while it was recorded at 5.47 for the last single week of trading, and 2.04 for the last 200 days.
Insight into OPKO Health Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and OPKO Health Inc. [OPK] shares currently have an operating margin of -21.79 and a Gross Margin at +29.34. OPKO Health Inc.’s Net Margin is presently recorded at -34.92.
Return on Total Capital for OPK is now -9.99, given the latest momentum, and Return on Invested Capital for the company is -16.27. Return on Equity for this stock declined to -18.49, with Return on Assets sitting at -13.23. When it comes to the capital structure of this company, OPKO Health Inc. [OPK] has a Total Debt to Total Equity ratio set at 19.57. Additionally, OPK Total Debt to Total Capital is recorded at 16.37, with Total Debt to Total Assets ending up at 13.68. Long-Term Debt to Equity for the company is recorded at 18.06, with the Long-Term Debt to Total Capital now at 15.10.
Reflecting on the efficiency of the workforce at the company, OPKO Health Inc. [OPK] managed to generate an average of -$51,661 per employee. Receivables Turnover for the company is 5.64 with a Total Asset Turnover recorded at a value of 0.38.OPKO Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.90 and a Current Ratio set at 1.10.
OPK Stock EPS
With the latest financial reports released by the company, OPKO Health Inc. posted -0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.11/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 9.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OPK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for OPKO Health Inc. go to 12.00%.
OPKO Health Inc. [OPK] Insider Position Details
There are presently around $865 million, or 25.10% of OPK stock, in the hands of institutional investors. The top three institutional holders of OPK stocks are: VANGUARD GROUP INC with ownership of 37,371,822, which is approximately -0.46% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 35,448,971 shares of the stock with an approximate value of $187.88 million in OPK stocks shares; and STATE STREET CORP, currently with $97.73 million in OPK stock with ownership of nearly 3.029% of the company’s market capitalization.
Positions in OPKO Health Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 78 institutional holders increased their position in OPKO Health Inc. [NASDAQ:OPK] by around 14,586,119 shares. Additionally, 89 investors decreased positions by around 23,384,056 shares, while 47 investors held positions by with 125,259,077 shares. The mentioned changes placed institutional holdings at 163,229,252 shares, according to the latest SEC report filing. OPK stock had 23 new institutional investments in for a total of 1,107,994 shares, while 31 institutional investors sold positions of 9,398,539 shares during the same period.